Probiotic Pearls Advantage by Integrative Therapeutics — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

1 Capsule(s) Serving Size

60 Servings

Non-Nutrient/Non-Botanical Product Type

100% Evidence Coverage

Supplement Facts — Evidence Check

Proprietary Probiotic Blend

26 mg

📊 Market median: 80.0mg (20 products) 📚 334 studies (Tier A: 8, B: 183)

This product: 26mg

Other Ingredients

Palm Oil Gelatin Glycerin Sunflower Lecithin Pectin Soy Lecithin

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (99% of products) Structure/Function (91% of products) Nutrient (14% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Recommendation: Adults swallow 1 capsule daily with water or your favorite beverage, or as recommended by a healthcare professional. May be taken with or without food. Do not chew or crush.

⚠️ Warnings & Precautions

Contains milk, soy, and fish (Tilapia).

If you are pregnant, nursing, or taking any medications, consult a healthcare professional prior to use.

Keep out of reach of children.

This product has a tamper-evident foil pouch. Do not use if foil or plastic is punctured.

🧪 Formulation Notes

Guaranteed Delivery

Probiotic Pearls Advantage 5 Billion CFU Active Cultures

Contains no salt, wheat, or artificial colors.

Product of Japan

Additional Information

For more information, please visit integrativepro.com

Store at room temperature. Avoid excessive heat and direct sunlight.

Product Details

UPC / SKU 8 71791 00448 1

DSLD Entry Date 2024-04-23

Product Type Non-Nutrient/Non-Botanical

Form Capsule

Brand Integrative Therapeutics

DSLD ID 313851

Data Updated 2026-04-11

Research Evidence

691 Research Sources

52 Avg Quality Score

255 Clinical Trial

205 Meta Analysis

123 Rct

81 Systematic Review

18 Cochrane Review

2 Guideline

2 Regulatory Source

1 Other

1 Narrative Review

1 Openfda Safety

A Probiotics for preventing acute upper respiratory tract infections

Systematic Review The Cochrane database of systematic reviews 2022

PubMed DOI Cochrane

A Probiotics for preventing acute upper respiratory tract infections

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

A Probiotics for maintenance of remission in ulcerative colitis

Meta Analysis The Cochrane database of systematic reviews 2020

PubMed DOI

A Probiotics for induction of remission in ulcerative colitis

Meta Analysis The Cochrane database of systematic reviews 2020

PubMed DOI

A Probiotics for preventing acute upper respiratory tract infections

Meta Analysis The Cochrane database of systematic reviews 2011

PubMed DOI Cochrane

A Probiotics for treating eczema

Meta Analysis The Cochrane database of systematic reviews 2018

PubMed DOI Cochrane

A Probiotics for treating acute infectious diarrhoea

Meta Analysis The Cochrane database of systematic reviews 2020

PubMed DOI

A The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies

Systematic Review International journal of molecular sciences 2022

PubMed DOI

A Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children

Meta Analysis The Cochrane database of systematic reviews 2017

PubMed DOI

A Probiotics to prevent infantile colic

Meta Analysis The Cochrane database of systematic reviews 2019

PubMed DOI

View all evidence for Probiotics →